IMS Health Holdings Inc (IMS) : Tpg-axon Management Lp has sold out all of its stake in IMS Health Holdings Inc during the most recent quarter, according to the disclosure filed by the company on Aug 15, 2016 with the SEC. The investment management company has sold out 1,131,018 shares of IMS Health Holdings Inc which is valued at $33,410,272.
Other Hedge Funds, Including , Two Sigma Advisers Lp added IMS to its portfolio by purchasing 1,389,016 company shares during the most recent quarter which is valued at $41,031,533. IMS Health Holdings Inc makes up approx 0.20% of Two Sigma Advisers Lp’s portfolio.Geode Capital Management reduced its stake in IMS by selling 95,637 shares or 9.62% in the most recent quarter. The Hedge Fund company now holds 898,578 shares of IMS which is valued at $26,543,994. IMS Health Holdings Inc makes up approx 0.01% of Geode Capital Management’s portfolio. Andra Ap-fonden added IMS to its portfolio by purchasing 49,500 company shares during the most recent quarter which is valued at $1,462,230. IMS Health Holdings Inc makes up approx 0.04% of Andra Ap-fonden’s portfolio.Mitsubishi Ufj Kokusai Asset Management Ltd. boosted its stake in IMS in the latest quarter, The investment management firm added 834 additional shares and now holds a total of 23,470 shares of IMS Health Holdings Inc which is valued at $694,477. IMS Health Holdings Inc makes up approx 0.02% of Mitsubishi Ufj Kokusai Asset Management Ltd.’s portfolio.
IMS Health Holdings Inc opened for trading at $29.83 and hit $29.92 on the upside on Thursday, eventually ending the session at $29.85, with a gain of 0.10% or 0.03 points. The heightened volatility saw the trading volume jump to 7,09,081 shares. Company has a market cap of $9,827 M.
On the company’s financial health, IMS Health Holdings Inc reported $0.41 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.38. The company had revenue of $1576.00 million for the quarter, compared to analysts expectations of $799.33 million. The company’s revenue was up 112.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.37 EPS.
IMS Health Holdings Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Companys data set contains over 10 petabytes of data and over 500 million patient records. The Company serves healthcare organizations and life science companies including pharmaceutical biotechnology consumer health and medical device manufacturers as well as distributors providers payers government agencies policymakers researchers and the financial community. The Companys principal offerings include national information offerings sub-national information offerings workflow analytics real-world evidence (RWE) solutions technology and applications and clinical solutions.